PTEN and cancer: The genetic duet of concurrent RASAL1 and PTEN alterations forms a unique genetic mechanism that robustly promotes oncogenesis and cancer aggressiveness through cooperatively activating the PI3K pathway, which can be further aggravated by coexisting TP53 alterations.